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Abstract - Inositol 1,4,5-trisphosphate (IP3) induced Ca2+ release in digitonin permeabllized 
rat pancreatic acinar cells is specifically inhibited by decavanadate. The ca2+ release 
induced with 0.18 flM IP3 is half maximally inhibited with approximately 5 flM decavanadate. 
Complete inhibition is achieved with around 20 flM decavanadate. Removal of decavanadate 
from the permeabilized cells fully restores sensitivity towards IP3, indicating the reversibility 
of the inhibition. Oligovanadate, which inhibits A TP dependent ca2+ up1ake into intracellular 
stores, does not influence IP3 induced ca2+ release. In order to reveal the mechanism 
underlying the effects of the different vanadate species, binding of IP3 to the same cellular 
preparations was investigated. We found that binding of IP3 to a high affinity receptor site 
(I<d approx. 1.2 nM) could be abolished by decavanadate but not by oligovanadate. With 0.5 
f.1M decavanadate, IP3 binding was half maximally inhibited. A similar potency of 
decavanadate was also found with adrenal cortex microsomes which bind IP3 with the same 
affinity (Kd approx. 1.4 nM) as permeabilized pancreatic acinar cells. Labelled IP3 was 
displaced from these subcellular membranes with similar kinetics by unlabelled IP3 and 
decavanadate. The data suggest that the inhibitory action of decavanadate on IP3 induced 
Ca2+ release is a consequence of its effect on binding of IP3 to its receptor. 
Intracellular inositol 1,4,5-trisphosphate (IP3), latter was shown for the fIrst time with 
fOImed at the plasma membrane by the hydrolysis of pelTIleabilized rat pancreatic acinar cells [2] and was 
phosphatidylinositol-4,5-bisphosphate, causes the subsequently confltmed by innumerable 
release of Ca2+ from intracellular stores [1]. The investigations in a variety of cells. Our knowled~e 
conceming the mechanism of the IP3 induced Ca + 
release is still limited although the primary structure 
of the IP3 receptor has been detetmined [3, 4]. A 
useful tool to characterize the IP3 receptor is 
heparin. It inhibits binding of IP3 to its receptor 
[5-7] and IP3 induced cl+ release [8-10]. The 
isolation of the IP3 receptor on heparin agarose and 
Abbreviations used : EGTA, ethylene-glycol-bis 
(2-aminoethylether)-N,N,N',N'-tetraacetic acid; EDTA, 
ethylenediaminetetraacetic acid; PEG, polyethylene glycol; 
!P3, inositol 1,4,5-trisphosphate; MOPS, morpholino-
propane sulfonic acid; HEPES, N-(2-hydroxyethyl)-
piperazine-N'-2-ethanesulfonic acid; Tris, tris(hydroxy-
methyl)-aminomethane 
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its incorporation into lipid vesicles led to the 
conclusion that the IP3 receptor itself fonns the 
Ca2+ channel [11]. 
In a previous report we introduced decavanadate 
as a specific inhibitor of the IP3 induced Ca2+ 
release of rat insulinoma and rat pheochromocytoma 
cells [12]. In the present study we focused our 
interest on rat pancreatic acinar cells, which are 
sirnilar to permeabilized chromaffin cells [13], but 
in contrast 10 the above mentioned tumor cells 
require GTP during the repetitive IP3 induced Ca2+ 
release [14]. The investigation of decavanadate 
effects on Caz+ release in these different cell types 
is of interest. since heparin reportedly only inhibits 
the IP3 induced Ca2+ release, wbereas the GTP-
activated ci+ translocation is unaffected [9]. Here 
we sbow that decavanadate completely inbibits IP3 
induced and GTP modulated Ca2+ release from 
perrneabilized pancreatic acinar ceHs, indicating that 
decavanadate influences a step in the Caz+ release 
mechanism common 10 several different cell types. 
Furthennore, we found that decavanadate inhibits 
binding of IP3 to its receptor in penneabilized 
pancreatic acinar cells as weIl as in isolated adrenal 
cortex microsomes. By contrast, the related com-
pound oligovanadate, wbicb inhibits ATP dependent 
Caz+ uptake into intracellular stores, bas no effect 
on IP3 induced Ca2+ release or binding of IP3 10 its 
receptor protein. Tbus, oligovanadate and deca-
vanadate are higbly selective substances which 
specifically inhibit either Ca2+ uptake or CaZ+ 
release by the IP3 sensitive intracellular CaZ+ store. 
Materials and Methods 
Chemieals 
Collagenase was purchased from Serva (Heidelberg, 
Gennany). Soybean trypsin inbibitor and IP3 were 
from Boehringer (Mannheim, Gennany). eH]-IP3 
(specific activity 17 Ci/rumol) was from New 
England Nuclear (UK). ci+ selective membranes 
containing the neutral carrier ETH 129 were 
prepared as described [15]. KCI suprapur was from 
Merck (Darmstadt. Gennany). and Azur A was from 
Fluka (Neu-Ulm, Gerrnany). All other cbemicals 
were of analytical grade. 
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Isolation 0/ exocrine pancreatic aci7UlT' cells 
Pancreatic acinar cells were prepared as described 
previously [16] with modifications according to 
[17]. Briefly, pancreatic tissue from four male 
Wistar rats (200-250 g) fasted overnight was 
chopped with scissors and incubated in a standard 
medium containing (in mM): 145 NaCl, 4.7 KCI, 
1.2 KHzP04, 1.2 MgClz, 2 CaC}z, 10 HEPES (pH 
7.4), 15 glucose, 0.2 % BSA, 0.01 % soybean 
trypsin inhibitor plus collagenase (150 U/ml) for 15 
min at 37°C. In order to get single cells a washing 
step in the above Caz+ free medium (CaC12 replaced 
by 1 mM EDTA, without collagenase) was 
interposed, followed by a further digestion by 
collagenase (210 U/ml) for 50-60 min at 37°C. 
DUTing cell isolation the medium was continuously 
gassed with oxygen in a water bath at 37°C. Acinar 
cells were then mechanically dissociated by 
sequential passages through polypropylene pipettes 
of decreasing tip diameter (about 5, 3 and 2 mm) 
after 40 min of the second collagenase digestion 
step. Tbe cell suspension was diluted with standard 
medium, and centrifuged for 5 min at 85 g. The 
pellet was resuspended in standard buffer and 
filtered through a double layer of medical gauze, 
placed over 30 ml of standard medium containing 
8% albumin. Tbe suspension was centrifuged again. 
Finally, the pellet was wasbed three times in the 
standard medium as described above. 
Permeabilization of pancreatic acinar cells with 
digitonin 
The resultant cell suspension was wasbed three 
times by centrifugation (80 gay, 3 min) in medium A 
containing in mM: 150 KCl, 5 NaN3, 1 EGTA and 
20 MOPS (pH 7.2). Penneabilization was carried 
out on ice with 10 f.1M digitonin wbicb was added to 
medium A from a stock where it was dissolved in 
dimethyl sulfoxide (DMSO). Tbe fmal concentration 
of DMSO was less than 0.1 %. Permeabilization 
was controlled by counting the Azur A (0.25 % in 
medium A) stained cells. Following permeabiliz-
ation, the cells were wasbed three times in medium 
B (medium A without EGTA) by centrifugation 
(400 gay, 3 min). 
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Measurement Offree Ca2+ concentration 
Ca2+ specific mini-electrodes were prepared as 
described [15]. Ca2+ specific electrodes were 
calibrated using the same ionic background for 
calibration as used for Ca2+ measurements. The poly 
(vinyl chloride) membrane of tbe electrode 
contained tbe recently developed neutral carrier 
ETH 129, which allows reliable measurements of 
ci+ down to the nanomolar range [18, 19]. 
Experiments were carried out at room temperature 
and pH 7.2 in 400 ~ of medium B containing 3-6 x 
106 ceHs. 107 ceHs correspond to 1.5 mg of cell 
protein. During Ca2+ uptake experiments, medium B 
contained 1 mM Ml+ and 20 ~ ATP, and during 
Ca2+ release experiments, medium B contained 2 
mM Mg2+ and 2 mM ATP [14]. The absolute 
amount of Ca2+ fluxes was calibrated in each 
experiment by the addition of suitable dilutions of a 
neutral Ca2+ standard (Orlon, Lorch, Gennany). 
Guanine nucleotides were present during Ca2+ 
measurements as indicated in tbe figure captions. 
Preparation of bovine adrenal cortex microsomes 
Bovine adrenal glands were obtained from tbe local 
slaughter house. Cortex microsomes were essentially 
prepared as previously described [20]. Briefly, the 
isolated cortex of adrenal glands was homogenized 
in 20 mM NaHC03, 1 mM DIT, pH 8.0 in a 
Teflon-to-glass homogenizer with 5 strokes at 800 
revslmin. The homogenate was centrifuged at 5000 
g, 4T for 15 min and rehomogenized. From tbe 
pooled supematants, the microsomes were spun 
down at 100 000 g, 4"C for 30 min and the pellet 
was washed again. The final pellet was resuspended 
in the homogenisation buffer described above at a 
protein concentration of 5 mg/ml and stored at 
-20°C. 
Determination of /P3 binding 
IP3 binding assays were carried out according to the 
metbod of Challis [20]. Briefly, digitonin per-
meabilized cells were washed three times by centri-
fugation (450 gay, 3 min) in a medium containing 
in mM: 100 Tris, 20 MOPS, 240 sucrose, 2 EDTA, 
2 EGTA, 2% PEG and a final pR of 8.0. Each assay 
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tube contained 0.9 DM eH]-IP3 (6000 cpmlassay) 
and unlabelled IP3 as indicated in the figure 
captions. The assays were carried out at 4°C with 
0.5 mg protein of penneabilized cells or 0.4 mg 
protein of adrenal cortex microsomes in a fmal 
volume of 400 ~. During the incubation (15 min), 
samples were vortex-mixed every 3 min. Thereafter, 
bound and free IP3 were separated by centrifugation 
(10 000 g, 30 s) in an OIe Dich microcentrifuge 
154. The supematant was aspirated and the pellet 
dissolved in 5 ml scintillant. NonsI>trific binding 
(NSB) was defined as binding of eH]-IP3 in the 
presence of 2 ~ lP3 (final). 
Preparation of defined vanadate species 
Oligovanadate and decavanadate were prepared as 
described [12] with the following modifications. In 
order to avoid high salt concentrations (due to 
dissolving of vanadate in 1 M KOR), crystals of 
orthovanadate were dissolved in medium B as a 
stock of 50 mM. For the preparation of deca-
vanadate, the pH was adjusted to 3.75 and for the 
preparation of oligovanadate the pH was adjusted to 
7.2 with HCl. Finally the preparations were boiled 
for 5 min. Oligovanadate concentrations refer to the 
monomeric form. 
Results and Discussion 
Decavanadate inhibits IP3 induced Ca2+ release 
In the presence of 5 mM sodium azide (NaN3) and 2 
mM Mg2+ / A TP, permeabilized exocrine pancreatic 
acinar cells sequester Ca2+ mainly within non-
mitochondrial intracellular Ca2+ stores [14]. The 
application of submicromolar concentrations of 
inositol 1,4,5-trisphosphate results in a transient 
Ca2+ release which is followed by the immediate 
2+ 
reuptake of released Ca . In the presence of 20 ~ 
GTP, a constant Ca2+ release occurs during the 
repeated application of the same amount of IP3 from 
permeabilized pancreatic acinar cells (Fig. 1: see 
also [14]). Streptolysin 0 penneabilized cbromaffm 
cells exhibit tbe same behaviour [13]. We found that 
increasing concentrations of decavanadate dose 
dependently inhibited tbe ea2+ transients induced by 
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performed with penneabilized cells, i.e. with cellular 
preparations identical to that used for the 
investigation of Ca2+ fluxes. A 50% displacement of 
the labelIed ligand (0.9 nM eH]-IP3) was attained 
with 1.2 nM of unlabelled ligand (Fig. 4a). 
0.<4-
Ä I--t I ++ Scatchard-analysis of these data revealed a binding ~~ nmol) capacity of 140 finol IP3/mg cell protein (Fig. 4b). The binding of eH]-IP3 by penneabilized pancreatic acinar cells was potently inhibited by decavanadate 
1P3 (0.25 ,.t.I) 5 mln 
Fig. 1 ea2+ release by lP3 pulses in the presence of GTP from 
permeabilized pancreatic acinar ceHs. 
Ca2+ fluxes of digitonin (10 J.1M) penneabilized pancreatic acinar 
ceHs (5.9 x 106 ceHs) were recorded with a Ca2+ selective 
electrode. The presence of 20 11M GTP in medium B (containing 
in mM: 2 Ml+/ATP, 5 NaN3, 150 KCl, 20 MOPS pH 7.2) 
assured constant ea2+ release during the repeated application of 
0.25 11M IP3 
IP3 (Fig. 2a). With 0.18 JlM IP3, half maximal 
inhibition occurred with around 5 JlM decavanadate 
which was complete with 20 JlM decavanadate (Fig. 
2b). A similar half maximal effective decavanadate 
concentration was reported for rat insulinoma and 
rat pheochromocytoma ceHs [12]. 
The inhibition of the IP3 induced Ca2+ release 
by decavanadate can not be explained by a 
decreased Ca2+ uptake, since decavanadate, unlike 
oli~ovanadate, did not influence the A TP driven 
Ca + uptake (Fig. 3). On the other hand, oligo-
vanadate did not affect the IP3 induced Ca2+ release 
(not shown). Thus decavanadate specifically affects 
the IP3 induced Ca2+ release, while the action of 
oligovanadate is restricted to the Ca2+ uptake 
system. Furthennore, removing decavanadate by 
centrifugation and repeating the same experiment 
after resuspending the cells resulted in a full 
response to IP3 (not shown). This indicates that the 
inhibition of the IP3 induced Ca2+ release by 
decavanadate is reversible. 
Decavanadate displaces IP3from its receptor 
The structural similarity of decavanadate (V1002S6-) 
[21, 22] with IP3 suggested that they might interact 
with the same sites. Therefore, we investigated the 
effects of different vanadate species on binding of 
IP3 to its receptor. These studies were also 
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(a) ea2+ transients were recorded under identical conditions as 
described in Figure 1. Increasing amounts of decavanadate were 
added stepwise to the permeabilized ceHs immediately before 
stimulation with 0.18 11M IP3. The addition of decavanadate did 
not change medium free Ca2+ concentration by itself, but it 
inhibited the subsequent ci+ release induced by IP3 
(b) Summary of 5 independent experiments as shown in Figure 
2a (means ± SD). 100% corresponds to the Ca2+ release in the 
absence of decavanadate 
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Fig. 3 Effect of oligo- and decavanadate on A TP driven Ca2+ 
uptake. 
Effects on Ca2+ uptake were estimated by inducing transient Ca2+ 
uptake with low concentrations of ATP (20 pM; see also [12, 
l3]). 100% corresponds to a ci+ uptake of 2.5 to 3.8 nmol 
Ci+1107 cells (n = 5) which was carried out in the absence of 
vanadate. Oligo- or decavanadate were added in increasing 
amounts immediately prior to the additions of A TP. Vanadate 
concentrations refer to the monomeric form 
(half maximal effective concentration of 0.5 ~), 
whereas oligovanadate was completely ineffective, 
even when tested at concentrations of 500 ~ (Fig. 
5). Thus, it can be concluded that the inhibition of 
the IP3 induced Ca2+ release by decavanadate in 
pancreatic acinar cells is a consequence of the 
displacement of IP3 from its binding site. 
In order to establish the effects of decavanadate 
on IP3 binding, we also performed IP3 binding 
studies with isolated adrenal cortex microsomes, 
which are rich in IP3 receptors and bind IP3 with the 
same affinity as pancreatic acinar ceHs. We found a 
Kd of 1.4 uM and 2.3 pmol binding sites per mg 
protein. For adrenal cortical microsomes, half 
maximal displacement occurred around 0.5 ~ 
decavanadate, whereas 500 ~ oligovanadate was 
completely ineffective in displacing IP3 (Fig. 6). 
Both 2 ~ IP3 and 25 ~ decavanadate resulted in 
a very similar and rapid dissociation of labelIed IP3 
from the receptor (Fig. 7). 
The dissociation constant (1.2 nM) for the 
binding of IP3 to its receptor in rat pancreatic acinar 
ceHs reported here is in the same order of magnitude 
as reported for permeabilized rat liver ceHs [23], 
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Fig. 4 Binding of IP3 to permeabilized pancreatic acinar cells. 
-6 
(a) Digitonin permeabilized cells (500 JIg cell protein) were 
incubated with 0.9 nM eH]-lP:l and increasing concentrations of 
unlabelled IP3. Specific binding is expressed as the percentage of 
eHJ-IP3 bound in the presence of various concentrations of 
unlabelled IP3 (B) and in the absence of unlabelled lP:l (Bo), with 
each value corrected for nonspecific binding (NSB). Nonspecific 
binding was defmed in the presence of 2 pM unlabelled IP3 and 
was typically 30% of total binding. The graph shows one out of 
three similar experiments carried out in triplicate 
(b) Scatchard plot of a single representative experiment with 
triplicate deterrninations of each point. The data were fitted by 
linear regression. In three experiments a Kd - 1.2 nM and B""", -
140 fmoVmg of protein were estimated 
whereas submicromolar dissociation constants bave 
been reported for permeabilized guinea pig 
hepatocytes and rabbit neutrophils [24]. Similarly 
the dissociation constant (1.4 nM) for the bin ding of 
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Fig. 5 Oecavanadate inhibits binding of lP3 to its receptor in 
permeabilized pancreatic acinar cells. 
Permeabilized cells were incubated with 0.9 nM eH]-1P3 and 
different concentrations of decavanadate (OV) and oligovanadate 
(OV). Nonspecific binding (NSB) was defined as binding in the 
presence of 2 J1M unlabelled 1P3. 100% corresponds to the 
binding of eHJ-1P3 in the absence of vanadate species and in the 
absence of unlabelled 1P3. The figure shows the mean (± SO) of 
3 independent experiments carried out in triplicate. Oligovanadate 
refers to the monomeric fonn 
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Fig. 6 Oecavanadate inhibits binding of lP3 to its receptor from 
adrenal cortex microsomes. 
Isolated adrenal cortex microsomes (0.4 mg protein) were 
incubated in a fmal volume of 400 J.Ll with 0.9 nM eH]-1P3 and 
different concentrations of decavanadate (Oeca) and 
oligovanadate (Oligo). For experimental details, see Materials and 
Methods. The figure shows the mean (± SO) of 3 independent 
experiments carried out in triplicate. Oligovanadate refers to the 
monomeric form 
IP3 to isolated adrenal cortex microsomes is in 
accordance with the Kd value reported for isolated 
microsomes from different cell types [20, 25, 26]. 
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Although the estimated IP3 concentration which 
causes half maximal ea2+ release (approx. 0.2 IJM 
at 0.2 IJM free ea2+; see also [13]) is in accordance 
with the observation of other anthors (see [1, 27, 
13]) it contrasts with the dissociation constant for 
IP3 (1.2 nM) found within the same cellular 
preparation. A similar discrepancy, when comparing 
displacement of IP3 from its receptor with its 
potency in Ca2+ mobilization, was also observed 
with microsomes from the adrenal cortex [26, 28]. 
In this context, the higher amounts of decavanadate 
(5 IJM) required for a half maximal inhibition of the 
50 IP3 induced Ca2+ release compared to the inhibition 
Fig. 7 Oisplacement of eH]-1P3 from adrenal cortex microsomes 
by unlabelled IP3 and decavanadate. 
The time dependent association of eHJ-1P3 (0.9 nM) with the 
receptor of adrenal cortex microsomes (circles) was detennined. 
After IS min, either 2 J1M unlabelled 1P3 (squares) or 2S J1M 
decavanadate (triangles) were added as indicated by the arrow. 
100% corresponds to the binding of eH]-1P3 as detennined after 
30 min. The data in this figure are representative of 1 out of 3 
independent experiments 
of IP3 binding (0.5 IJM decavanadate) are not 
unexpected. A similar behaviour was also reported 
for heparin which inhibits binding of IP3 to its 
receptor protein and IP3 induced Ca2+ release, as 
does decavanadate [10]. Certainly some of these 
differences rnay be explained by the different 
experimental conditions used for the different 
assays. Besides the difference in ionic strength and 
pR, it should be noted that the Ca2+ release 
experiments (to keep Ca2+ in the store) IDUst be 
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carried out in the presence of millimolar 
concentrations of Mg2+ and A TP, while displace-
ment assays are carried out in their absence. Both 
Mg2+ and ATP affect IP3 metabolism [29, 30] and 
binding of IP3 [7, 20, 23]. Under our experimental 
conditions, 1 mM A TP reduced IP3 binding to about 
10% of that measured in the absence of ATP. 
Identical values for IP3 binding and Ca2+ releasing 
potency have recently been reported using identical 
conditions for both assays [23]. 
Conclusions 
In conclusion, decavanadate appears to be the most 
useful inhibitor of IP3 induced Ca2+ release and 
inhibitor of IP3 binding to its receptor protein. 
Compared to decavanadate, rather high con-
centrations of other polyanions (patent blue, 
cibacron blue) have been reported to displace IP3 
frorn its receptor [31], but the effects of these 
substances on subsequent steps leading to IP3 
induced Ca2+ release have not been elucidated. 
Additionally, decavanadate-mediated inhibition 
provides a sensitive marker to assess IP3 binding 
sites in penneabilized cells, microsome fractions and 
IP3 receptor preparations. Finally, the small 
rnolecular size and wen defined chemical structure 
[21, 22] of decavanadate furnish important advant-
ages over heparin for further characterization of the 
IP3 binding site on its receptor. 
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